Your prediction
Protalix Biotherapeutics Inc. Stock
Heavy losses for Protalix Biotherapeutics Inc. today as the stock fell by -€0.070 (-3.350%).
Our community identified positive and negative aspects for Protalix Biotherapeutics Inc. stock for the coming years. 3 users see the criterium "Worthwhile Investment for the next years" as a plus for the Protalix Biotherapeutics Inc. stock. On the other hand our users think that "Growth compared to competition" could be a problem in the future.
Pros and Cons of Protalix Biotherapeutics Inc. in the next few years
Pros
?
C******** o* t** e**********
?
M***** P*******
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Protalix Biotherapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Protalix Biotherapeutics Inc. | -3.350% | -0.713% | 7.732% | 58.333% | 36.601% | 54.472% | 48.227% |
| Intellia Therapeutics Inc | 1.060% | -5.126% | -33.050% | -18.445% | 20.933% | -74.773% | -91.932% |
| Chromadex Corp | 0.000% | -4.196% | -4.196% | -65.316% | -50.182% | 82.667% | -67.765% |
| Cardio3 Biosciences S.A. | 11.160% | 2.752% | 6.667% | -31.707% | 65.926% | -53.719% | -94.035% |
